Long-term evaluation in BALBc mice of a triple mutant of Mycobacterium bovis and the Bacillus Calmette-Guérin as potential vaccines against bovine tuberculosis
There is currently no commercial vaccine available against bovine tuberculosis (bTB). Mycobacterium bovis is the primary causative agent of bTB and is closely related to Mycobacterium tuberculosis, the pathogen responsible for human TB. Despite their limitations, mouse models are invaluable in early...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | info:ar-repo/semantics/artículo |
| Lenguaje: | Inglés |
| Publicado: |
Elsevier
2025
|
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/20.500.12123/21369 https://www.sciencedirect.com/science/article/abs/pii/S0378113525000069 https://doi.org/10.1016/j.vetmic.2025.110371 |
Ejemplares similares: Long-term evaluation in BALBc mice of a triple mutant of Mycobacterium bovis and the Bacillus Calmette-Guérin as potential vaccines against bovine tuberculosis
- Mycobacterium bovis mutant in the virulence factors PhoP, ESAT-6 and CFP-10 persisted in mouse organs after a year post-vaccination
- M72 Fusion proteins in nanocapsules enhance BCG efficacy against bovine tuberculosis in a mouse model
- A DIVA-compatible Mycobacterium bovis triple mutant vaccine confers protection against bovine tuberculosis in mouse model
- Replication and transmission features of two experimental vaccine candidates against bovine tuberculosis subcutaneously administrated in a murine model
- Comparative study of two deleted Mycobacterium bovis strains in experimental animal models
- Dynamics of the in vitro growing of Mycobacterium bovis from the lungs of vaccinated and infected mice